Neuroleptic Malignant Syndrome After the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder
Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse reaction to neuroleptics, which is characterized by hyperthermia, extrapyramidal symptoms, altered consciousness and autonomic dysfunction. Although NMS is most commonly induced by the high-potency neuroleptics, its development has...
Main Authors: | Tsung-Chien Lu, Wen-Jone Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-01-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664609601157 |
Similar Items
-
Low dosage of aripiprazole induced neuroleptic malignant syndrome after interaction with other neuroleptic drugs
by: Albino Petrone, et al.
Published: (2013-09-01) -
Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus
by: Ali Ertug Arslankoylu, et al.
Published: (2011-06-01) -
Neuroleptic malignant syndrome: a fatal case with unusual features
by: U. M. Wariyapperuma, et al.
Published: (2014-12-01) -
Neuroleptic Malignant Syndrome and Methylphenidate
by: J Gordon Millichap
Published: (1998-12-01) -
Neuroleptic Malignant Syndrome Associated with Lithium Toxicity
by: Vaibhav Patil, et al.
Published: (2016-07-01)